Core Viewpoint - The article discusses the increasing life expectancy in China and the associated challenges of an aging population, emphasizing the need for innovative healthcare solutions and technologies to improve the quality of life for the elderly [3][6][12]. Group 1: Life Expectancy and Aging Population - The National Health Commission aims to raise the average life expectancy in China from 79 years in 2024 to around 80 years by 2025 [3]. - As of the end of 2024, the elderly population (aged 60 and above) in China exceeds 310 million, indicating a significant aging trend [3]. - Experts highlight that improving life expectancy requires addressing the mortality rates of major diseases, particularly cardiovascular diseases and cancer [3][6]. Group 2: Cancer Treatment and Management - Cancer is becoming a manageable chronic disease, with advancements in immunotherapy being crucial for addressing the burden of high-incidence cancers like lung and stomach cancer [7]. - The establishment of early screening tools for cancer, particularly liver cancer, has shown promise in improving early diagnosis and treatment outcomes [8][9]. - The five-year survival rate for liver cancer patients at Zhongshan Hospital has reached 71% due to new technologies and proactive follow-up plans [8]. Group 3: Health Management and Technology Integration - Comprehensive health management strategies, including regular check-ups and early intervention for chronic diseases, are essential for increasing life expectancy [12][13]. - AI and wearable medical devices are being integrated into disease prevention and management, allowing for real-time monitoring of patients' health [14][15]. - The World Health Organization emphasizes the importance of expanding hypertension treatment coverage as a cost-effective health measure [14]. Group 4: Regenerative Medicine and Technological Innovations - Regenerative medicine, including stem cell therapy, is gaining attention as a potential solution for age-related health issues and organ repair [17][18]. - The Chinese government has introduced regulations to support the clinical research and application of new biomedical technologies, including stem cells [18]. - Innovations in elder care technology, such as fall detection systems and care robots, are being developed to address the challenges of an aging population [19][20]. Group 5: Challenges in Elderly Care Technology - There is a disconnect between the development of elderly care technologies and the actual needs of the elderly, leading to ineffective products [19]. - Experts call for collaboration between technology developers and elderly care providers to ensure that products meet the real needs of older adults [20].

Group 1 - The core objective is to increase China's average life expectancy to around 80 years by 2024, focusing on reducing mortality rates from major diseases, particularly cardiovascular diseases and cancer [1][3] - As of the end of 2024, the population aged 60 and above in China is expected to exceed 310 million, indicating a significant aging trend [1] - The development of innovative therapies and the application of new technologies, such as artificial intelligence, are essential to address the needs of the elderly population [1][7] Group 2 - Cancer is becoming a chronic disease, with advancements in medical technology and health levels contributing to increased life expectancy [3][4] - Eight provinces in China have already surpassed an average life expectancy of 80 years, with health indicators ranking among high-income countries [3] - The focus on immune system reconstruction is crucial for combating diseases like cancer, as highlighted by recent Nobel Prize-winning research [3] Group 3 - The burden of diseases such as lung and stomach cancer necessitates breakthroughs in tumor immunotherapy, positioning China as a key player in the precision immunotherapy era [4] - The development of early screening tools for cancer, particularly liver cancer, has shown promise in improving early diagnosis and treatment outcomes [5][8] - The five-year survival rate for liver cancer patients post-surgery has reached 71% due to advancements in treatment and follow-up care [5] Group 4 - AI and big data are being leveraged for disease management, emphasizing the importance of health management practices such as regular check-ups and early intervention for chronic diseases [7][9] - The integration of AI in cardiovascular disease management aims to enhance diagnosis and treatment through comprehensive patient data analysis [9][10] - The World Health Organization emphasizes the cost-effectiveness of expanding hypertension treatment coverage, which can be improved through digital health solutions [10] Group 5 - Regenerative medicine and stem cell research are gaining attention as potential solutions for age-related diseases, with the goal of improving both lifespan and quality of life [11][12] - The recent regulations on biomedical technology provide legal support for the development of cutting-edge medical technologies, including stem cell therapies [12] - The trend towards smart aging solutions is evident, with advanced technologies being integrated into elderly care to alleviate caregiver shortages [13][14]